Journal Article
Estimated Wasteful Spending on Aducanumab Dispensing in the U.S. Medicare Population: A Cross-Sectional Analysis
Aducanumab, a weight-dosed Alzheimer's drug, is available in two fixed-dose vial sizes. This may result in large amounts of discarded drug and wasteful spending. More-efficient vial sizes could save Medicare money if the drug is approved for widespread use.
Aug 11, 2022